|
Egui A, Thomas MC, Fernandez-Villegas A, Perez-Anton E, Gomez I, Carrilero B, Del Pozo A, Ceballos M, Andres-Leon E, Lopez-Ruz MA, Gainza E, Oquinena E, Segovia M, Lopez MC. A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection. Antimicrob Agents Chemother. 2019 Sep 23;63(10):e02436-18. doi: 10.1128/AAC.02436-18. Print 2019 Oct. PubMed PMID: 31358581; PubMed Central PMCID: PMC6761566.
AÑO: 2019; IF: 4.904
|
31358581
|
Gil-Gallardo L, Simon M, Iborra A, Carrilero B, Segovia M. Chemiluminescent Microparticle Immunoassay for the Diagnosis of Congenital Chagas Disease: A Prospective Study in Spain. Am J Trop Med Hyg. 2021 Oct 4;105(6):1701-1705. doi: 10.4269/ajtmh.21-0332. PubMed PMID: 34607304; PubMed Central PMCID: PMC8641311.
AÑO: 2021; IF: 3.707
|
|
Trueba-Argamasilla AA, Iborra-Bendicho MA, Simon-Paez M, Ros-de San Pedro J, Segovia-Hernandez M. Cerebral echinococcosis: Case report and literature review. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Aug 20:S0213-005X(21)00226-3. doi: 10.1016/j.eimc.2021.07.006. Online ahead of print. English, Spanish. PubMed PMID: 34426035.
AÑO: 2021; IF: 1.994
|
|
Gomez I, Thomas MC, Palacios G, Egui A, Carrilero B, Simon M, Valladares B, Segovia M, Carmelo E, Lopez MC. Differential Expression of Immune Response Genes in Asymptomatic Chronic Chagas Disease Patients Versus Healthy Subjects. Front Cell Infect Microbiol. 2021 Sep 6;11:722984. doi: 10.3389/fcimb.2021.722984. eCollection 2021. PubMed PMID: 34552885; PubMed Central PMCID: PMC8450343.
AÑO: 2021; IF: 6.073
|
|
Vazquez C, Garcia-Vazquez E, Carrilero B, Simon M, Franco F, Iborra MA, Gil-Gallardo LJ, Segovia M. Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole. Rev Soc Bras Med Trop. 2023 Jan 23;56:e0384-2022. doi: 10.1590/0037-8682-0384-2022. eCollection 2023. PubMed PMID: 36700605; PubMed Central PMCID: PMC9870279.
AÑO: 2023; IF: 1.8
|